| scholarly article | Q13442814 |
| P356 | DOI | 10.1021/JF802754S |
| P8608 | Fatcat ID | release_xsxnswcvhne57erirjhkqpwha4 |
| P698 | PubMed publication ID | 19053221 |
| P50 | author | William Mullen | Q42413974 |
| Richard C Hartley | Q43062207 | ||
| Stuart T Caldwell | Q50175663 | ||
| Christine A Edwards | Q56872505 | ||
| Alan Crozier | Q58215660 | ||
| P2093 | author name string | Cyril Auger | |
| Jean-Max Rouanet | |||
| Pierre-Louis Teissèdre | |||
| Micheal E J Lean | |||
| P2860 | cites work | Tissue distribution of quercetin in rats and pigs | Q48828295 |
| P433 | issue | 24 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 12127-12137 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Journal of Agricultural and Food Chemistry | Q1024905 |
| P1476 | title | Bioavailability of [2-(14)C]quercetin-4'-glucoside in rats | |
| P478 | volume | 56 |
| Q51803435 | 3,4-Dihydroxyphenylacetic acid is a potential aldehyde dehydrogenase inducer in murine hepatoma Hepa1c1c7 cells. |
| Q35941776 | 3,4-Dihydroxyphenylacetic acid, a microbiota-derived metabolite of quercetin, attenuates acetaminophen (APAP)-induced liver injury through activation of Nrf-2. |
| Q41682888 | A novel tag-free probe for targeting molecules interacting with a flavonoid catabolite. |
| Q26770108 | Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine |
| Q37801023 | Berry flavonoids and phenolics: bioavailability and evidence of protective effects. |
| Q34057398 | Bioavailability challenges associated with development of anti-cancer phenolics |
| Q38245598 | Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: an update |
| Q37801022 | Colonic metabolites of berry polyphenols: the missing link to biological activity? |
| Q41127173 | Comparison of the urinary excretion of quercetin glycosides from red onion and aglycone from dietary supplements in healthy subjects: a randomized, single-blinded, cross-over study |
| Q37902937 | Conjugated quercetin glucuronides as bioactive metabolites and precursors of aglycone in vivo |
| Q27002456 | Dietary (poly)phenolics in human health: structures, bioavailability, and evidence of protective effects against chronic diseases |
| Q90310627 | Dietary Quercetin and Kaempferol: Bioavailability and Potential Cardiovascular-Related Bioactivity in Humans |
| Q37688791 | Electrophiles in foods: the current status of isothiocyanates and their chemical biology |
| Q35159402 | In silico prediction and automatic LC-MS(n) annotation of green tea metabolites in urine |
| Q26782337 | Metabolic and Microbial Modulation of the Large Intestine Ecosystem by Non-Absorbed Diet Phenolic Compounds: A Review |
| Q35122803 | Microsomal quercetin glucuronidation in rat small intestine depends on age and segment. |
| Q43129212 | Oral bioavailability of quercetin from different quercetin glycosides in dogs |
| Q42702455 | Quercetin Metabolites Up-Regulate the Antioxidant Response in Osteoblasts Isolated From Fetal Rat Calvaria |
| Q84615115 | Quercetin and Ferulic Acid Aggravate Renal Carcinoma in Long-Term Diabetic Victims |
| Q43294351 | Quercetin metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats |
| Q43148116 | Radiolabelled cyanidin 3-O-glucoside is poorly absorbed in the mouse |
| Q43177098 | Relative bioavailability of the flavonoids quercetin, hesperetin and naringenin given simultaneously through diet. |
| Q89701860 | Structure-antioxidant activity relationship of methoxy, phenolic hydroxyl, and carboxylic acid groups of phenolic acids |
| Q57090620 | Synthesis of polyhydroxylated flavonoids bearing a lipophilic decyl tail as potential therapeutic antioxidants |
| Q46271930 | Systematic review of the effects of the intestinal microbiota on selected nutrients and non-nutrients |
| Q33842761 | The pharmacokinetics of anthocyanins and their metabolites in humans |
Search more.